{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T01:22:55Z","timestamp":1791508975246,"version":"4.3.4"},"reference-count":21,"publisher":"MDPI AG","issue":"23","license":[{"start":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["22-15-00473-\u041f"],"award-info":[{"award-number":["22-15-00473-\u041f"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>CFTR modulators have significantly affected the prognosis for cystic fibrosis, improving the clinical course in most patients with the F508del variant and several other CFTR gene variants. The presence of complex alleles, including more than one variant in the cis position, can change the properties of the protein and the efficacy of modulators. Objective: We aimed to describe the efficacy of CFTR modulators in the treatment of two siblings with the c.[1521_1523delCTT;1399C&gt;T];[54-5940_273+10250del21kb] (L467F;F508del\/CFTRdele2,3) genotype in clinical practice and in vitro. This article presents the clinical presentation and results of CFTR channel function assessment and personalized selection of CFTR modulators in monochorionic diamniotic twins with cystic fibrosis and the L467F;F508del\/CFTRdele2,3 genotype. This is the first demonstration of the efficacy of a new CFTR modulator in patients with a complex allele and a class I variant in the genotype. The obtained results may be useful for choosing treatment strategies for patients with a complex allele and a class I variant in the genotype.<\/jats:p>","DOI":"10.3390\/ijms262311742","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T13:53:30Z","timestamp":1764856410000},"page":"11742","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["L467F;F508del Complex Allele in a Heterozygous State with CFTRdele2,3: What to Expect from CFTR Modulators?"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6395-0407","authenticated-orcid":false,"given":"Elena","family":"Kondratyeva","sequence":"first","affiliation":[{"name":"Research Centre for Medical Genetics, 1 Moskvorechye St., 115552 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5035-6396","authenticated-orcid":false,"given":"Anna","family":"Efremova","sequence":"additional","affiliation":[{"name":"Research Centre for Medical Genetics, 1 Moskvorechye St., 115552 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8814-5532","authenticated-orcid":false,"given":"Yuliya","family":"Melyanovskaya","sequence":"additional","affiliation":[{"name":"Research Centre for Medical Genetics, 1 Moskvorechye St., 115552 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2195-3025","authenticated-orcid":false,"given":"Maria","family":"Krasnova","sequence":"additional","affiliation":[{"name":"Research Centre for Medical Genetics, 1 Moskvorechye St., 115552 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Milovanov","sequence":"additional","affiliation":[{"name":"Research Centre for Medical Genetics, 1 Moskvorechye St., 115552 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4905-1303","authenticated-orcid":false,"given":"Olga","family":"Shchagina","sequence":"additional","affiliation":[{"name":"Research Centre for Medical Genetics, 1 Moskvorechye St., 115552 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0416-8137","authenticated-orcid":false,"given":"Anna","family":"Stepanova","sequence":"additional","affiliation":[{"name":"Research Centre for Medical Genetics, 1 Moskvorechye St., 115552 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8183-7990","authenticated-orcid":false,"given":"Anna","family":"Voronkova","sequence":"additional","affiliation":[{"name":"Research Centre for Medical Genetics, 1 Moskvorechye St., 115552 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2206-1528","authenticated-orcid":false,"given":"Victoria","family":"Sherman","sequence":"additional","affiliation":[{"name":"Research Centre for Medical Genetics, 1 Moskvorechye St., 115552 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3133-8018","authenticated-orcid":false,"given":"Sergey","family":"Kutsev","sequence":"additional","affiliation":[{"name":"Research Centre for Medical Genetics, 1 Moskvorechye St., 115552 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2438-1605","authenticated-orcid":false,"given":"Dmitry","family":"Goldshtein","sequence":"additional","affiliation":[{"name":"Research Centre for Medical Genetics, 1 Moskvorechye St., 115552 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,12,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/apa.15155","article-title":"Cystic fibrosis in the year 2020: A disease with a new face","volume":"109","year":"2020","journal-title":"Acta Paediatr."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1136\/thoraxjnl-2021-216849","article-title":"Lung function in children with cystic fibrosis in the USA and UK: A comparative longitudinal analysis of national registry data","volume":"77","author":"Ostrenga","year":"2022","journal-title":"Thorax"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Ancel, J., Launois, C., Perotin, J.M., Ravoninjatovo, B., Mulette, P., Hagenburg, J., Malet, J., Griffon, M., Carr\u00e9, S., and Lebargy, F. (2022). Health-Related Quality of Life in Adults with Cystic Fibrosis: Familial, Occupational, Social, and Mental Health Predictors. Healthcare, 10.","DOI":"10.3390\/healthcare10071351"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1007\/s00431-021-04168-y","article-title":"A new era for people with cystic fibrosis","volume":"180","author":"Bierlaagh","year":"2021","journal-title":"Eur. J. Pediatr."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"20406223221098136","DOI":"10.1177\/20406223221098136","article-title":"New drugs in cystic fibrosis: What has changed in the last decade?","volume":"13","author":"Roda","year":"2022","journal-title":"Ther. Adv. Chronic Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"8382","DOI":"10.1038\/ncomms9382","article-title":"Genome-wide association meta-analysis identifies five modifier loci of lung disease severity in cystic fibrosis","volume":"6","author":"Corvol","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"9045","DOI":"10.1074\/jbc.M008979200","article-title":"Two mild cystic fibrosis-associated mutations result in severe cystic fibrosis when combined in cis and reveal a residue important for cystic fibrosis transmembrane conductance regulator processing and function","volume":"276","author":"Clain","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jcf.2018.12.011","article-title":"Predictive factors for lumacaftor\/ivacaftor clinical response","volume":"18","author":"Masson","year":"2019","journal-title":"J. Cyst. Fibros."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Terlizzi, V., Centrone, C., Ferrari, B., Castellani, C., Gunawardena, T.N.A., Taccetti, G., and Laselva, O. (2022). Modulator Therapy in Cystic Fibrosis Patients with cis Variants in F508del Complex Allele: A Short-Term Observational Case Series. J. Pers. Med., 12.","DOI":"10.3390\/jpm12091421"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1074\/jbc.275.5.3561","article-title":"A naturally occurring sequence variation that creates a YY1 element is associated with increased cystic fibrosis transmembrane conductance regulator gene expression","volume":"275","author":"Romey","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"5126","DOI":"10.3390\/cimb44100349","article-title":"Personalized Selection of a CFTR Modulator for a Patient with a Complex Allele [L467F;F508del]","volume":"44","author":"Kondratyeva","year":"2022","journal-title":"Curr. Issues Mol. Biol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"283","DOI":"10.18093\/0869-0189-2024-34-2-283-288","article-title":"Contribution of the intestinal current measurement method to assessment of the efficacy of CFTR modulators in cystic fibrosis","volume":"34","author":"Melyanovskaya","year":"2024","journal-title":"PULMONOLOGIYA"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Sondo, E., Cresta, F., Pastorino, C., Tomati, V., Capurro, V., Pesce, E., Lena, M., Iacomino, M., Baffico, A.M., and Coviello, D. (2022). The L467F-F508del complex allele hampers pharmacological rescue of mutant CFTR by elexacaftor\/tezacaftor\/ivacaftor in cystic fibrosis patients: The value of the ex vivo nasal epithelial model to address personalized therapy. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23063175"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Petrova, N.V., Kashirskaya, N.Y., Vasilyeva, T.A., Balinova, N.V., Marakhonov, A.V., Kondratyeva, E.I., Zhekaite, E.K., Voronkova, A.Y., Kutsev, S.I., and Zinchenko, R.A. (2022). High frequency of complex CFTR alleles associated with c.1521_1523delCTT (F508del) in Russian cystic fibrosis patients. BMC Genom., 23.","DOI":"10.1186\/s12864-022-08466-z"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Efremova, A., Melyanovskaya, Y., Krasnova, M., Voronkova, A., Mokrousova, D., Zhekaite, E., Bulatenko, N., Makhnach, O., Bukharova, T., and Kutsev, S. (2024). Estimation of Chloride Channel Residual Function and Assessment of Targeted Drugs Efficiency in the Presence of a Complex Allele [L467F;F508del] in the CFTR Gene. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms251910424"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jcf.2024.12.006","article-title":"Sweat chloride reflects CFTR function and correlates with clinical outcomes following CFTR modulator treatment","volume":"24","author":"Zemanick","year":"2025","journal-title":"J. Cyst. Fibros."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S2213-2600(24)00411-9","article-title":"Vanzacaftor-tezacaftor-deutivacaftor versus elexacaftor-tezacaftor-ivacaftor in individuals with cystic fibrosis aged 12 years and older (SKYLINE Trials VX20-121-102 and VX20-121-103): Results from two randomised, active-controlled, phase 3 trials","volume":"13","author":"Keating","year":"2025","journal-title":"Lancet Respir. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/humu.23389","article-title":"Cis-variants identified in complex alleles F508del modulate the CFTR channel restoration by small molecules","volume":"39","author":"Baatallah","year":"2018","journal-title":"Hum. Mutat."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Ramalho, A.S., Boon, M., Proesmans, M., Vermeulen, F., Carlon, M.S., and Boeck, K. (2022). Assays of CFTR Function In Vitro, Ex Vivo and In Vivo. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23031437"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1136\/thx.2009.125088","article-title":"Intestinal current measurement for diagnostic classification of patients with questionable cystic fibrosis: Validation and reference data","volume":"65","author":"Derichs","year":"2010","journal-title":"Thorax"},{"key":"ref_21","first-page":"55159","article-title":"Forskolin-induced swelling in intestinal organoids: An in vitro assay for assessing drug response in cystic fibrosis patients","volume":"120","author":"Boj","year":"2017","journal-title":"J. Vis. Exp."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/23\/11742\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T13:58:21Z","timestamp":1764856701000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/23\/11742"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,4]]},"references-count":21,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["ijms262311742"],"URL":"https:\/\/doi.org\/10.3390\/ijms262311742","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,4]]}}}